Skip to main content
. 2021 Nov 18;11:768993. doi: 10.3389/fcimb.2021.768993

Figure 1.

Figure 1

Immune cross-reactivity of convalescent patient serums with SARS collected from 15 years post-infection against the SARS-CoV-2 spike protein. (A) Heatmap of antibody titres. (B) Histogram of antibody titres expressed in terms of mean and 95% confidence interval (CI). (C) Histogram of OD450 in the ACE2 competition assay in terms of mean and 95% CI. (D) Heatmap of OD450 in the ACE2 competition assay. ****P < 0.0001. ns, no significant difference.